Browse by Section 100 Item List

HIGHLY SPECIALISED DRUGS PROGRAM (Public Hospital)

For Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Department of Human Services. Maximum quantities and repeats for Highly Specialised Drugs are listed in the Schedule. Highly Specialised Drugs prescribed through public hospitals, except Complex Authority Required Highly Specialised Drugs, are Authority required (STREAMLINED) PBS Prescriptions. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats. Complex Authority Required Highly Specialised Drugs require written authority applications. Approval of authority prescriptions by Department of Human Services may be obtained either by posting an Authority Prescription Form to Department of Human Services, or by using Department of Human Services' Authority Freecall service (1800 888 333). Prescribers must quote the provider number of the hospital when applying.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies. A patient will be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the Pharmaceutical Benefits Scheme. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 9560E TACROLIMUStacrolimus 1 mg capsule, 100 2 200 5
MP 9665Q TACROLIMUStacrolimus 1 mg capsule: modified release, 60 capsules 2 120 5
MP 9561F TACROLIMUStacrolimus 5 mg capsule, 50 2 100 5
MP 9666R TACROLIMUStacrolimus 5 mg capsule: modified release, 30 capsules 2 60 5
MP 9558C TACROLIMUStacrolimus 500 microgram capsule, 100 2 200 5
MP 9664P TACROLIMUStacrolimus 500 microgram capsule: modified release, 30 capsules 2 60 5
MP 1308W TADALAFILtadalafil 20 mg tablet, 56 1 56 0
MP 2437G TELAPREVIRtelaprevir 375 mg tablet, 42 6 252 0
MP 9562G TELBIVUDINEtelbivudine 600 mg tablet, 28 2 56 5
MP 9563H TENOFOVIRtenofovir disoproxil fumarate 300 mg tablet, 30 2 60 5
MP 9564J TENOFOVIR + EMTRICITABINEtenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 2 60 5
MP 9565K TENOFOVIR + EMTRICITABINE + EFAVIRENZtenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30 2 60 5
MP 10088Y TENOFOVIR + EMTRICITABINE + ELVITEGRAVIR + COBICISTATtenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 2 60 5
MP 9667T THALIDOMIDEthalidomide 100 mg capsule, 28 2 56 0
MP 9566L THALIDOMIDEthalidomide 50 mg capsule, 28 4 112 0
MP 9567M TIPRANAVIRtipranavir 250 mg capsule, 120 2 240 5
MP 10056G TOCILIZUMABtocilizumab 200 mg/10 mL injection, 1 x 10 mL vial 1 1 0
MP 10058J TOCILIZUMABtocilizumab 200 mg/10 mL injection, 1 x 10 mL vial 1 1 0
MP 1481Y TOCILIZUMABtocilizumab 200 mg/10 mL injection, 1 x 10 mL vial 1 1 0
MP 9658H TOCILIZUMABtocilizumab 200 mg/10 mL injection, 1 x 10 mL vial 1 1 0
MP 10064Q TOCILIZUMABtocilizumab 400 mg/20 mL injection, 1 x 20 mL vial 1 1 0
MP 10072D TOCILIZUMABtocilizumab 400 mg/20 mL injection, 1 x 20 mL vial 1 1 0
MP 1482B TOCILIZUMABtocilizumab 400 mg/20 mL injection, 1 x 20 mL vial 1 1 0
MP 9659J TOCILIZUMABtocilizumab 400 mg/20 mL injection, 1 x 20 mL vial 1 1 0
MP 10077J TOCILIZUMABtocilizumab 80 mg/4 mL injection, 1 x 4 mL vial 1 1 0
MP 10081N TOCILIZUMABtocilizumab 80 mg/4 mL injection, 1 x 4 mL vial 1 1 0
MP 1476Q TOCILIZUMABtocilizumab 80 mg/4 mL injection, 1 x 4 mL vial 1 1 0
MP 9657G TOCILIZUMABtocilizumab 80 mg/4 mL injection, 1 x 4 mL vial 1 1 0